On October 17, 2018, Canada entered a new era of the assumed and uncomplicated legalization of cannabis. It became the first G7 country to allow the cultivation and use of cannabis for recreational purposes. There is little doubt that this historic decision will give food for thought to other governments, which are closely monitoring the Canadian experiment.
As such, a diffusion of this model to other Western economies would necessarily be accompanied by an exponential growth of the cannabis industry, which is still in its infancy, offering many investment opportunities with it. Real sectors are being set up, economic models are emerging, all under the watchful eye of giants in the agri-food and pharmaceutical industries.
It is within this framework that a real asset class is emerging, with its own standards in terms of volatility and growth. The cannabis industry is indeed one of the sectors with the highest growth rates but still remains composed of non-profit actors. Market expectations are thus high and delays in achieving the objectives communicated are severely sanctioned, the price to pay to support confusing growth rates.
This thematic list targets producers who play an important role in the research, production, processing and sale of cannabis for medical and recreational use.